Good post Nellq!
While immediate revenue, is not important to a Company like Brainchip, according to the short sighted view of the ASX, it is.
This will be forcibly changed, by the demand from outside exchanges in the future, I believe.
And most certainly, if/when we list on the NASDAQ, within the next 1 to 2 years.
The ASX is resource dominated, so it is best to look at Brainchip's future income streams as resources.
Each IP deal we land, is like the discovery of a new gold resource.
We know it's there, but we don't yet know how far down, or across, the mineralization extends.
As new products come out, from our IP licences, we get a better idea, of how big that resource is.
The main difference between a gold resource and an IP resource, is that there is little cost to the Company in finding that resource (negotiations instead of drilling) and once discovered, we do not need to spend additional money to drill and define the resource further. Our customers do it for us.
Also unlike a gold resource an IP resource does not run out (assuming continued use) and the income streams only grow.
Maybe that's why the NASDAQ, values tech companies, the way it does..
Here's hoping for the discovery of new resources soon!
My opinions only.
GLTAH!
GLTAS!
- Forums
- ASX - By Stock
- BRN
- 2022 BRN Discussion
2022 BRN Discussion, page-2846
-
-
- There are more pages in this discussion • 8,077 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $333.0M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 16.8¢ | $794.8K | 4.640M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
63 | 1370737 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 82218 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 702664 | 0.170 |
60 | 1398429 | 0.165 |
68 | 1501073 | 0.160 |
24 | 1011519 | 0.155 |
72 | 1925420 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 993838 | 19 |
0.180 | 1625289 | 39 |
0.185 | 866975 | 22 |
0.190 | 1512823 | 23 |
0.195 | 1045102 | 16 |
Last trade - 11.05am 13/08/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online